scispace - formally typeset
M

Massimo Santoro

Researcher at University of Turin

Publications -  185
Citations -  15848

Massimo Santoro is an academic researcher from University of Turin. The author has contributed to research in topics: Thyroid carcinoma & Thyroid. The author has an hindex of 66, co-authored 173 publications receiving 14778 citations. Previous affiliations of Massimo Santoro include Flanders Institute for Biotechnology & University of Eastern Piedmont.

Papers
More filters
Journal ArticleDOI

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.

TL;DR: A novel activated oncogene resulted from the rearrangement of an unknown amino-terminal sequence to the tyrosine kinase domain of the ret proto-oncogene and was detected by transfection analysis in five out of 20 primary human thyroid papillary carcinomas and in the available lymph node metastases.
Journal ArticleDOI

ROS homeostasis and metabolism: a dangerous liason in cancer cells.

TL;DR: How the mitochondria has a key role in regulating the interplay between redox homeostasis and metabolism within tumor cells is described, and the potential therapeutic use of agents that directly or indirectly block metabolism is discussed.
Journal ArticleDOI

Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27 Kip1 by PKB/Akt-mediated phosphorylation in breast cancer

TL;DR: It is demonstrated that the serine/threonine kinase Akt regulates cell proliferation in breast cancer cells by preventing p27kip1-mediated growth arrest and cytoplasmic relocalization of p27Kip1, secondary to Akt-mediated phosphorylation, is a novel mechanism whereby the growth inhibitory properties of p 27kip 1 are functionally inactivated and the proliferation of breast cancer Cells is sustained.
Journal ArticleDOI

Cellular and molecular facets of keratinocyte reepithelization during wound healing

TL;DR: Findings in wound biology clarified the molecular pathways governing keratinocyte reepithelization at wound sites point towards novel therapeutic targets and provide suitable methods to promote faster tissue regeneration in vivo.